Global Contrast Media Injectors Market Report and Forecast 2024-2032

Global Contrast Media Injectors Market Outlook:

The global contrast media injectors market size was valued at USD 1.61 billion in 2023, driven by the rising number of cardiovascular disease and cancer accompanied with technological advancements and increasing investments in healthcare sector. The market size is anticipated to grow at a CAGR of 7.20% during the forecast period of 2024-2032 to achieve a value of USD 3.01 billion by 2032.

Contrast Media Injectors: Introduction

Contrast media, also known as contrast agents, are devices used to inject contrast agents into the patient’s body during any diagnostic imaging procedures, like computed tomography, MRI, and angiography, to increase the image quality through enhanced visibility of blood vessels, organs, or specific tissues. Contrast agent injector enhances the precision in the procedure by preventing against any undesirable formation of air emboli, caused by inappropriate contrast material injection. Devices used in the procedure are also diverse in nature offering single head, dual- head, and syringe less injectors to allow accurate and precise delivery of contrast agents.

Global Contrast Media Injectors Market Analysis

The rising number of cancer and cardiovascular diseases, accompanied by technological advancements and increasing investment by governmental and healthcare bodies, are some of the key factors contributing to the contrast media injectors market growth. Recent developments in the market showcased the involvement of IT-enabled contrast media injectors to avoid any human errors while performing this procedure. Involvement of automated injectors in the procedure not only control the amount of contrast used but will also offer a more personalized dosage for patients with the help of electronic medical record or other communication systems.

Global Contrast Media Injectors Market Segmentations

Based on segments, the market is divided into product type, type, applications, end user, and region.

Market Breakup by Product Type

• Injector Systems
  • CT Injector Systems
  • MRI Injector Systems
  • Cardiovascular/Angiography Injector Systems
• Consumables
  • Tubing
  • Syringe
  • Others

Market Breakup by Type

• Single Head Injectors

• Dual-Head Injectors

• Syringe less Injectors

Market Breakup by Applications

• Radiology

• Interventional Cardiology

• Interventional Radiology

• Others

Market Breakup by End User

• Hospitals

• Diagnostics Centres

• Ambulatory Surgery Centres

• Others

Market Breakup by Region

• North America 

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Contrast Media Injectors Market Overview

Advances in medical science and technology have made contrast media a routine procedure in the field of diagnosis. Over the years, with rapid improvement in technology, these contrast injectors have also evolved from manual injectors to more sophisticated and precise automated injectors, also known as autoinjectors. These autoinjectors have the capability to control the volume of media injected, utilization rate and the flow of dosage to keep pace with the medical imaging scanners. These improvements have made these devices more reliable and efficient, leading to a higher contrast media injectors market demand. Growing awareness about the benefits of early diagnosis of diseases has also led to an increase in the use of contrast media injectors.

Among the regional markets, North America has been accounting for the largest contrast media injectors market share and is anticipated to continue leading the global market owing to the higher presence of key players.

Global Contrast Media Injectors Market: Competitor Landscape

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following contrast media injector companies, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• General Electric

• Vivid Imaging Solutions

• Hilin Life Products, Inc.

• Jodas Expoim Pvt. Ltd.

• Lantheus

• Magnus Health

• TAEJOON PHARM

• Spago Nanomedical AB

• Guerbet

• Bracco

• Bayer AG

• Medtron AG

• NemotoKyorindo Co., Ltd.

• ulrich GmbH & Co. KG

• Sino Medical-Device Technology Co.

Key Highlights of the Report